시장보고서
상품코드
1908538

의료기기용 바이오플라스틱 시장 규모, 점유율 및 동향 분석 보고서 : 재료별, 용도별, 지역별 및 부문별 예측(2025-2033년)

Bioplastics In Medical Devices Market Size, Share & Trends Analysis Report By Material (PLA, PHA, PBS / PBAT), By Application (Single-use Disposables, Sterile Packaging & Trays, Diagnostic Consumables), By Region And Segment Forecasts, 2025 - 2033

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의료기기용 바이오플라스틱 시장 개요

세계의 의료기기용 바이오플라스틱 시장 규모는 2024년 21억 1,000만 달러로 평가되었고, 2033년 50억 6,000만 달러에 이를 것으로 예측됩니다.

2025-2033년에 걸쳐 CAGR 10.3%로 성장할 전망입니다. 최소 침습적 시술에 대한 수요 증가로 인해 바이오플라스틱으로 제작된 가볍고 유연하며 환자 친화적인 부품의 사용이 확대되고 있습니다.

병원들은 이러한 소재가 더 안전한 기기 설계를 지원하면서도 폐기물 처리 비용을 절감하기 때문에 선호합니다. 의료 기기용 바이오플라스틱 수요는 틈새 연구에서 대규모 임상 적용으로 전환되고 있습니다. 일시적 임플란트, 흡수성 봉합사, 일회용 소모품은 수명 주기 혜택과 낮은 내재 탄소량으로 인해 점점 더 많이 지정되고 있습니다. 제조사들은 병원 및 의료 기술 기업의 증가하는 조달 수요를 충족시키기 위해 소재 인증 및 공급망 확장에 투자하고 있습니다. 이러한 움직임은 확대되는 시장 전망과 부문별 분석에 의해 뒷받침됩니다.

촉진요인, 기회, 제약

규제 기관과 대형 병원 시스템은 일회용 플라스틱 폐기물 및 탄소 회계 관련 요건을 강화하고 있습니다. 구매자들은 이제 임상적으로 적합한 경우 산업용 퇴비화나 제어된 생분해와 같은 수명 종료 옵션을 가능하게 하는 소재를 선호합니다. 이러한 정책과 조달 신호는 기기 OEM 업체들이 바이오플라스틱 대안을 검증하고 동등한 안전성 및 멸균 성능을 입증하도록 압박합니다. 기술 문헌은 또한 의료용 등급 바이오폴리머에 대한 연구 개발이 증가하고 있음을 기록하고 있습니다.

바이오플라스틱은 일시적 기능성이 요구되는 부문에서 OEM 업체들에게 제품 차별화의 명확한 경로를 제공합니다. 흡수성 정형외과용 핀, 조직 재생용 스캐폴드, 생분해성 전달체는 2차 시술 필요성을 줄이고 총 치료 비용을 절감할 수 있습니다. 비용, 가공, 규제 서류 측면의 격차를 해소하는 선구적 기업들은 지속가능성 목표를 추구하는 의료 시스템과의 프리미엄 입찰에서 우위를 점할 수 있습니다. 시장 전망은 특정 의료용 생분해성 플라스틱 부문의 상당한 성장 잠재력을 시사합니다.

임상 도입은 멸균 호환성, 제어된 분해 속도, 장기 생체 적합성 데이터 요구사항에 의해 제약을 받습니다. 최근 연구에서는 일부 전분 기반 및 생분해성 제형의 첨가제 독성과 미세 파편 행동에 대한 의문도 제기되었습니다. 동시에 원료 및 규모 제한으로 인해 단위 비용이 일반 폴리머보다 높게 유지됩니다. 이러한 기술적·경제적 장벽이 복합적으로 작용하여 검증된 저비용 공급망과 명확한 안전성 데이터가 등장하기 전까지는 대규모 조달이 지연됩니다.

자주 묻는 질문

  • 의료기기용 바이오플라스틱 시장 규모는 어떻게 예측되나요?
  • 의료기기용 바이오플라스틱의 주요 촉진 요인은 무엇인가요?
  • 의료기기용 바이오플라스틱의 주요 용도는 무엇인가요?
  • 의료기기용 바이오플라스틱 시장의 주요 재료는 무엇인가요?
  • 의료기기용 바이오플라스틱 시장의 지역별 전망은 어떻게 되나요?
  • 의료기기용 바이오플라스틱 시장의 경쟁 구도는 어떻게 되나요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 의료기기용 바이오플라스틱 시장의 변수, 동향 및 범위

  • 시장 계통 전망
    • 상위 시장 전망
  • 침투율과 성장 전망의 매핑
  • 산업 밸류체인 분석
    • 주요 밸류체인 참가자의 이익률 분석
    • 원료의 동향
    • 원료 가격 분석
  • 기술 개요
    • 상업 생산 기술
    • 기술 진보의 로드맵(2021-2030년)
  • 지속가능성의 동향
    • 재활용 및 순환형 경제
  • 평균 가격 동향 분석(2021-2030년)
    • 가격 설정에 영향을 미치는 주요 요인
    • 수급 격차 분석
  • 규제 프레임워크
    • 시책과 인센티브 계획
    • 기준과 규제 준수
    • 규제의 영향 분석
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTEL 분석
    • 정치적 환경
    • 경제환경
    • 사회적 환경
    • 기술적 환경
    • 환경적 상황
    • 법적 환경

제4장 의료기기용 바이오플라스틱 시장 : 재료별, 전망 및 추정 및 예측

  • 의료기기용 바이오플라스틱 시장 : 재료별 변동 분석(2024년, 2033년)
    • PLA
    • PHA
    • PBS/PBAT
    • 기타

제5장 의료기기용 바이오플라스틱 시장 : 용도별, 추정 및 예측

  • 의료기기용 바이오플라스틱 시장 : 용도별 변동 분석(2024년, 2033년)
    • 일회용 제품
    • 멸균 포장 및 트레이
    • 진단용 소모품
    • 임베디드형
    • 기타

제6장 의료기기용 바이오플라스틱 시장 : 지역별, 추정 및 예측

  • 지역별 개황
  • 의료기기용 바이오플라스틱 시장 : 지역별 변동 분석(2024년, 2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 사우디아라비아
    • 남아프리카
    • 아랍에미리트(UAE)

제7장 경쟁 구도

  • 주요 시장 진출기업에 의한 최근의 동향 및 영향 분석
  • 벤더 상황
    • 기업 분류
    • 주요 유통업체와 채널 파트너 목록
    • 잠재 고객/최종 사용자 목록
  • 경쟁환경
    • 기업 점유율 분석 및 시장 포지셔닝
    • 경쟁 벤치마킹
    • 전략 매핑
    • 히트맵 분석
  • 기업 프로파일/목록
    • NatureWorks LLC
    • Danimer Scientific
    • BASF SE
    • TotalEnergies Corbion
    • Novamont SpA
    • Mitsubishi Chemical Corporation
    • Toray Industries, Inc.
    • Biome Bioplastics Limited
    • FKuR Kunststoff GmbH
    • RWDC Industries
HBR 26.01.22

Bioplastics In Medical Devices Market Summary

The global bioplastics in medical devices market size was estimated at USD 2.11 billion in 2024 and is projected to reach USD 5.06 billion by 2033, growing at a CAGR of 10.3% from 2025 to 2033. The rising demand for minimally invasive procedures is driving the use of lightweight, flexible, and patient-friendly components made from bioplastics.

Hospitals prefer these materials because they support safer device designs while reducing waste handling costs. Demand for bioplastics in medical devices is shifting from niche research to scaled clinical use. Temporary implants, resorbable sutures, and single-use disposables are increasingly specified for their lifecycle benefits and lower embedded carbon. Manufacturers are investing in material qualification and supply-chain scale-up to meet rising procurement from hospitals and medtech firms. This movement is supported by expanding market forecasts and sector-specific analyses.

Drivers, Opportunities & Restraints

Regulators and large hospital systems are tightening requirements around single-use plastic waste and carbon accounting. Buyers now favor materials that enable end-of-life options such as industrial composting or controlled biodegradation, where clinically appropriate. These policies and procurement signals push device OEMs to validate bioplastic alternatives and to demonstrate comparable safety and sterilization performance. Technical literature also documents growing R&D into medical-grade biopolymers.

Bioplastics provide OEMs a clear path to product differentiation in categories where temporary functionality is required. Resorbable orthopedic pins, scaffolds for tissue regeneration, and biodegradable delivery carriers reduce the need for secondary procedures and can lower the total cost of care. Early movers who close gaps in cost, processing, and regulatory dossiers can capture premium tender positions with health systems pursuing sustainability targets. Market projections indicate significant upside potential for focused medical bioplastics segments.

Clinical adoption is constrained by sterilization compatibility, controlled degradation rates, and long-term biocompatibility data requirements. Recent studies have also raised questions about additive toxicity and microfragment behavior for some starch-based and biodegradable formulations. At the same time, feedstock and scale limitations keep unit costs higher than those of commodity polymers. These combined technical and economic barriers slow procurement at scale until validated, lower-cost supply chains and clearer safety data emerge.

Global Bioplastics In Medical Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global bioplastics in medical devices market report on the basis of material, application, and region:

  • Material Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
  • PLA
  • PHA
  • PBS / PBAT
  • Other Materials
  • Application Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
  • Single-use Disposables
  • Sterile Packaging & Trays
  • Diagnostic Consumables
  • Implantable
  • Other Applications
  • Regional Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Types & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Type & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Insights
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Bioplastics in Medical Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Profit Margin Analysis of Key Value Chain Participants
    • 3.3.2. Raw Material Trends
    • 3.3.3. Raw Material Price Analysis
  • 3.4. Technology Overview
    • 3.4.1. Commercial Production Technology
    • 3.4.2. Roadmap of Technology Advancement, 2021 to 2030
  • 3.5. Sustainability Trends
    • 3.5.1. Recycling and Circular Economy
  • 3.6. Average Price Trend Analysis, 2021 to 2030 (USD/kg)
    • 3.6.1. Key Factors Influencing Pricing
    • 3.6.2. Supply Demand Gap Analysis
  • 3.7. Regulatory Framework
    • 3.7.1. Policies and Incentive Plans
    • 3.7.2. Standards and Compliances
    • 3.7.3. Regulatory Impact Analysis
  • 3.8. Market Dynamics
    • 3.8.1. Market Driver Analysis
    • 3.8.2. Market Restraint Analysis
    • 3.8.3. Industry Challenges
  • 3.9. Porter's Five Forces Analysis
    • 3.9.1. Supplier Power
    • 3.9.2. Buyer Power
    • 3.9.3. Substitution Threat
    • 3.9.4. Threat from New Entrants
    • 3.9.5. Competitive Rivalry
  • 3.10. PESTEL Analysis
    • 3.10.1. Political Landscape
    • 3.10.2. Economic Landscape
    • 3.10.3. Social Landscape
    • 3.10.4. Technological Landscape
    • 3.10.5. Environmental Landscape
    • 3.10.6. Legal Landscape

Chapter 4. Bioplastics in Medical Devices Market: Material Outlook Estimates & Forecasts

  • 4.1. Bioplastics in Medical Devices Market: Material Movement Analysis, 2024 & 2033
    • 4.1.1. PLA
      • 4.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 4.1.2. PHA
      • 4.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 4.1.3. PBS / PBAT
      • 4.1.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 4.1.4. Other Materials
      • 4.1.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)

Chapter 5. Bioplastics in Medical Devices Market: Application Outlook Estimates & Forecasts

  • 5.1. Bioplastics in Medical Devices Market: Application Movement Analysis, 2024 & 2033
    • 5.1.1. Single-use Disposables
      • 5.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 5.1.2. Sterile Packaging & Trays
      • 5.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 5.1.3. Diagnostic Consumables
      • 5.1.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 5.1.4. Implantable
      • 5.1.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 5.1.5. Other Applications
      • 5.1.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)

Chapter 6. Bioplastics in Medical Devices Market Regional Outlook Estimates & Forecasts

  • 6.1. Regional Snapshot
  • 6.2. Bioplastics in Medical Devices Market: Regional Movement Analysis, 2024 & 2033
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 6.3.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
    • 6.3.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.3.4. U.S.
      • 6.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.3.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.3.4.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.3.5. Canada
      • 6.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.3.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.3.5.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.3.6. Mexico
      • 6.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.3.6.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.3.6.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
  • 6.4. Europe
    • 6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 6.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
    • 6.4.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.4.4. UK
      • 6.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.4.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.4.4.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.4.5. Germany
      • 6.4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.4.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.4.5.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.4.6. France
      • 6.4.6.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.4.6.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.4.6.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.4.7. Italy
      • 6.4.7.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.4.7.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.4.7.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.4.8. Spain
      • 6.4.8.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.4.8.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.4.8.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
  • 6.5. Asia Pacific
    • 6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 6.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
    • 6.5.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.5.4. China
      • 6.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.5.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.5.4.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.5.5. India
      • 6.5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.5.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.5.5.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.5.6. Japan
      • 6.5.6.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.5.6.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.5.6.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.5.7. South Korea
      • 6.5.7.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.5.7.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.5.7.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
  • 6.6. Latin America
    • 6.6.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 6.6.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
    • 6.6.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.6.4. Brazil
      • 6.6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.6.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.6.4.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.6.5. Argentina
      • 6.6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.6.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.6.5.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
  • 6.7. Middle East & Africa
    • 6.7.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
    • 6.7.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
    • 6.7.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.7.4. Saudi Arabia
      • 6.7.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.7.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.7.4.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.7.5. South Africa
      • 6.7.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.7.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.7.5.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)
    • 6.7.6. UAE
      • 6.7.6.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Tons)
      • 6.7.6.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Tons)
      • 6.7.6.3. Market estimates and forecast, by material, 2021 - 2033 (USD Million) (Tons)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Vendor Landscape
    • 7.2.1. Company categorization
    • 7.2.2. List of Key Distributors and channel Partners
    • 7.2.3. List of Potential Customers/End-users
  • 7.3. Competitive Dynamics
    • 7.3.1. Company Market Share Analysis & Market Positioning
    • 7.3.2. Competitive Benchmarking
    • 7.3.3. Strategy Mapping
    • 7.3.4. Heat Map Analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. NatureWorks LLC
      • 7.4.1.1. Participant's overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
    • 7.4.2. Danimer Scientific
      • 7.4.2.1. Participant's overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
    • 7.4.3. BASF SE
      • 7.4.3.1. Participant's overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
    • 7.4.4. TotalEnergies Corbion
      • 7.4.4.1. Participant's overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
    • 7.4.5. Novamont S.p.A.
      • 7.4.5.1. Participant's overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
    • 7.4.6. Mitsubishi Chemical Corporation
      • 7.4.6.1. Participant's overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
    • 7.4.7. Toray Industries, Inc.
      • 7.4.7.1. Participant's overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
    • 7.4.8. Biome Bioplastics Limited
      • 7.4.8.1. Participant's overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
    • 7.4.9. FKuR Kunststoff GmbH
      • 7.4.9.1. Participant's overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
    • 7.4.10. RWDC Industries
      • 7.4.10.1. Participant's overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제